Sirolimus-eluting stent for in-stent restenosis of left main coronary artery in Takayasu arteritis

Circulation Journal

Volumn 69, Issue 6, 2005, Pages 752-755

  Furukawa, Yutaka ^a   Tamura, Toshihiro ^a   Toma, Masanao ^a   Abe, Mitsuru ^a   Saito, Naritatsu ^a   Ehara, Natsuhiko ^a   Taniguchi, Ryoji ^a   Nakagawa, Yoshihisa ^a   Kita, Toru ^a   Kimura, Takeshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Left main coronary artery disease; Restenosis; Sirolimus eluting stent; Takayasu arteritis

Indexed keywords

PREDNISOLONE; RAPAMYCIN;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; AORTA ARCH SYNDROME; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; LEFT CORONARY ARTERY; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; FEMALE; HUMANS; MIDDLE AGED; SIROLIMUS; STENTS; TAKAYASU'S ARTERITIS;

EID: 20444413105     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.752     Document Type: Article

References (22)

1. Koide K. Takayasu arteritis in Japan. Heart Vessels Suppl 1992; 7: 48-54.
2. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis: A study of 32 North American patients. Medicine (Baltimore) 1985; 64: 89-99.
3. Cipriano PR, Silverman JF, Perlroth MG, Griepp RB, Wexler L. Coronary arterial narrowing in Takayasu's aortitis. Am J Cardiol 1977; 39: 744-750.
4. Endo M, Tomizawa Y, Nishida H, Aomi S, Nakazawa M, Tsurumi Y, et al. Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg 2003; 125: 570-577.
5. Matsubara O, Kuwata T, Nemoto T, Kasuga T, Numano F. Coronary artery lesions in Takayasu arteritis: Pathological considerations. Heart Vessels Suppl 1992; 7: 26-31.
6. Nakano S, Shimazaki Y, Kaneko M, Taniguchi K, Miyamoto Y, Takami H, et al. Transaortic patch angioplasty for left coronary ostial stenosis in a patient with Takayasu's aortitis. Ann Thorac Surg 1992; 53: 694-696.
7. Nishiyama A, Matsubara S, Toyama J. Takayasu arteritis with multiple cardiovascular complications. Heart Vessels 2001; 16: 23-27.
8. Kelley MP, Klugherz BD, Hashemi SM, Meneveau NF, Johnston JM, Matthai WH Jr, et al. One-year clinical outcomes of protected and unprotected left main coronary artery stenting. Eur Heart J 2003; 24: 1554-1559.
9. Black A, Cortina R, Bossi I, Choussat R, Fajadet J, Marco J. Unprotected left main coronary artery stenting: Correlates of midterm survival and impact of patient selection. J Am Coll Cardiol 2001; 37: 832-838.
10. Park SJ, Park SW, Hong MK, Lee CW, Lee JH, Kim JJ, et al. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol 2003; 91: 12-16.
11. Alfonso F, Cequier A, Zueco J, Moris C, Suarez CP, Colman T, et al. Stenting the stent: Initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis. Am J Cardiol 2000; 85: 327-332.
12. Sheiban I, Albiero R, Marsico F, Dharmadhikari A, Tzifos V, Pagnotta P, et al. Immediate and long-term results of "T" stenting for bifurcation coronary lesions. Am J Cardiol 2000; 85: 1141-1144, A9.
13. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249.
14. Iakovou I, Ge L, Michev I, Sangiorgi GM, Montorfano M, Airoldi F, et al. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions. J Am Coll Cardiol 2004; 44: 967-971.
15. Nomura M, Kida S, Yamashima T, Yamashita J, Yoshikawa J, Matsui O. Percutaneous transluminal angioplasty and stent placement for subclavian and brachiocephalic artery stenosis in aortitis syndrome. Cardiovasc Intervent Radiol 1999; 22: 427-432.
16. Chatterjee SS, Pahari DK, Sharma RK, Halder B, Roy S, Ghosh S, et al. Long term follow-up of percutaneous transluminal renal angioplasty with special reference to aorto-arteritis. Indian Heart J 1995; 47: 120-124.
17. Numano F, Ohta N, Sasazuki T. HLA and clinical manifestations in Takayasu disease. Jpn Circ J 1982; 46: 184- 189.
18. Inder SJ, Bobryshev YV, Cherian SM, Lord RS, Masuda K, Yutani C. Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease. Angiology 2000; 51: 565-579.
19. Seko Y. Takayasu arteritis: Insights into immunopathology. Jpn Heart J 2000; 41: 15-26.
20. Seko Y, Sugishita K, Sato O, Takagi A, Tada Y, Matsuo H, et al. Expression of costimulatory molecules (4-IBBL and Fas) and major histocompatibility class 1 chain-related A (MICA) in aortic tissue with Takayasu's arteritis. J Vasc Res 2004; 41: 84-90.
21. Flanagan WM, Crabtree GR. Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition. Ann NY Acad Sci 1993; 696: 31-37.
22. Chiang PH, Wang L, Bonham CA, Liang X, Fung JJ, Lu L, et al. Mechanistic insights into impaired dendritic cell function by rapamycin: Inhibition of Jak2/Stat4 signaling pathway. J Immunol 2004; 172: 1355-1363.